Avatrombopag in Patients With End-stage Liver Disease and Thrombocytopenia
- Status
- UNKNOWN
- Phase
- PHASE4
Clinical Trials Related to Thrombocytopenia
Related studies linked through entity extraction aliases.
Efficacy and Safety of Avatrombopag in Cancer Patients With Thrombocytopenia
- Status
- UNKNOWN
- Phase
- PHASE2
Collection of the Thrombo-VaxCov Cohort
- Status
- WITHDRAWN
- Phase
- N/A
Managed Access Programs for ETB115, Eltrombopag
- Status
- AVAILABLE
- Phase
- N/A
Contribution of Anti-platelet Antibodies Identified With MAIPA Assay in the Demonstration of the Auto-immune Character of a Thrombocytopenia at Diagnosis
- Status
- RECRUITING
- Phase
- NA
Avatrombopag for the Primary Prevention of Thrombocytopenia Induced by Cytarabine-based Chemotherapy in Patients With Lymphoma
- Status
- UNKNOWN
- Phase
- PHASE2
Using Romiplostim to Treat Low Platelet Counts During Chemotherapy in People With Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Thrombosomes® in Bleeding Thrombocytopenic Patients Study
- Status
- TERMINATED
- Phase
- PHASE2
Avatrombopag on the Treatment of Thrombocytopenia Induced by Chemotherapy of Malignant Tumors
- Status
- COMPLETED
- Phase
- NA
Fostamatinib as a Single Agent or in Combination With Ruxolitinib for Treatment of Patients With Myelofibrosis With Severe Thrombocytopenia
- Status
- TERMINATED
- Phase
- PHASE2
TPO-Mimetic Use in Children for Hematopoietic Failure
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
Avatrombopag for Thrombocytopenia in People With Cancer
- Status
- WITHDRAWN
- Phase
- PHASE2
Thrombocytopoiesis and Platelet Homeostasis in Infants With Bronchoplumonary Dysplasia
- Status
- COMPLETED
- Phase
- N/A
Characterization of New Candidate Genes in Cases of Human Inherited Thrombocytopenia (CATCH)
- Status
- COMPLETED
- Phase
- NA
Effects of a Platelet Transfusion Best Practices Alert
- Status
- COMPLETED
- Phase
- NA
Study of Human Umbilical Cord-derived Mesenchymal Stem Cells for Treatment of Refractory Immune Thrombocytopenia
- Status
- COMPLETED
- Phase
- NA
Idiopathic Chronic Thrombocytopenia of Undetermined Significance : Pathogenesis and Biomarker
- Status
- UNKNOWN
- Phase
- N/A
Evaluation of Immune Status Before and After Splenectomy in Immune Thrombocytopenia Patients
- Status
- RECRUITING
- Phase
- N/A
Platelet Transfusion in Sepsis Trial
- Status
- WITHDRAWN
- Phase
- NA
A Clinical Trial of Chidamide in the Management of Refractory ITP
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2